Pacientes con deterioro cognitivo leve y reducción de la proteína Aβ1-42 en LCR evolucionan rápidamente a enfermedad de Alzheimer

Our MCI patients with lower Aβ1-42 protein levels and an increased P-tau181p /Aβ1-42 ratio progressed quickly to AD. These results may help to identify those MCI patients with a poorer prognosis.